SCHEMBL24769779

SCHEMBL24769779

CCC(CC)(CCC(=O)O)c1csc(-c2ccccc2)n1

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.47
ALDH1A1 P00352 3/20 0.46
SMN1; SMN2 Q16637 4/20 0.44
MAPT P10636 3/20 0.44
MEN1 O00255 2/20 0.44
MAPK1 P28482 2/20 0.44
KMT2A Q03164 2/20 0.44
LMNA P02545 2/20 0.43
HPGD P15428 1/20 0.43
RAB9A P51151 4/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC8 Q9BY41 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
TSHR P16473 2/20 0.41
NPC1 O15118 3/20 0.41
TDP1 Q9NUW8 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24768598 0.74 NPC1 (0.56) KDM4EALDH1A1SMN1; SMN2MAPTMEN1
SCHEMBL513805 0.73 KDM4E (0.46) KDM4EALDH1A1SMN1; SMN2MAPTMEN1
SCHEMBL24769832 0.73 ALDH1A1 (0.51) KDM4EALDH1A1SMN1; SMN2MAPTMEN1
SCHEMBL38665488 0.72 GAA (0.70) KDM4EALDH1A1SMN1; SMN2MAPTMEN1
SCHEMBL10025209 0.70 SREBF2 (0.54) KDM4EALDH1A1SMN1; SMN2MAPTMEN1
SCHEMBL8483276 0.70 HIF1A (0.46) ALDH1A1SMN1; SMN2MAPTMEN1MAPK1
SCHEMBL24769834 0.69 GAA (0.56) KDM4EALDH1A1MAPTMEN1MAPK1
SCHEMBL24769826 0.69 ALDH1A1 (0.52) KDM4EALDH1A1SMN1; SMN2MAPTMEN1
SCHEMBL17742732 0.67 HDAC1 (0.60) KDM4EALDH1A1SMN1; SMN2MAPTMEN1
SCHEMBL2083581 0.67 KDM4E (0.49) KDM4EALDH1A1SMN1; SMN2MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12630515-B2 Small molecule prostagladin transport inhibitors ALBERT EINSTEIN COLLEGE OF MEDICINE (US) 2026-05-19 US disclosed
US-20220402881-A1 SMALL MOLECULE PROSTAGLADIN TRANSPORT INHIBITORS ALBERT EINSTEIN COLLEGE OF MEDICINE 2022-12-22 US disclosed
US-20220402881-A1 SMALL MOLECULE PROSTAGLADIN TRANSPORT INHIBITORS ALBERT EINSTEIN COLLEGE OF MEDICINE 2022-12-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220402881-A1 SMALL MOLECULE PROSTAGLADIN TRANSPORT INHIBITORS PTGER1, PTGIS, PTGIR KDM4E 4081/4885ALDH1A1 875/4885SMN1; SMN2 3813/4885
US-12630515-B2 Small molecule prostagladin transport inhibitors PTGER1, PTGS1, PTGIR KDM4E 4133/4885ALDH1A1 1715/4885SMN1; SMN2 3550/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.